Roche to buy US company GenMark Diagnostics
ZURICH: Swiss pharmaceutical company Roche said on Monday it was going to buy US GenMark Diagnostic Company for about $1.8 billion.
GenMark, headquartered in California, specializes in molecular testing. After purchasing the company, Roche will be able to perform a variety of tests from a single sample.
According to a statement issued by Roche, GenMark is valued at. 24.05 per share. Roche said the purchase of GenMark Diagnostics would add a new dimension to the company’s molecular testing.
If approved by the regulatory body, the procurement process will be completed in the second quarter of the current year. -RSS